(HealthDay)—The risk for breast cancer recurrence can be extracted using disease-specific survival data, according to a study published online Oct. 18 in Cancer Epidemiology, Biomarkers & Prevention.
Oct 30, 2018
0
0
Scientists fighting cancer have carried out the first successful trial of the effects of the antibiotic Doxycycline on cancer recurrence in patients after surgery.
Oct 2, 2018
0
53
This is a story about something rare in health psychology: a treatment that has gone from scientific discovery, through development and testing, to dissemination and successful implementation nationwide.
Sep 20, 2018
0
1
More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells—known as the PI3 kinase (PI3K) pathway—but efforts to develop therapies targeting this pathway have ...
Jun 25, 2018
0
39
Autologous fat transfer, also known as "lipofilling", is a minimally invasive procedure in which the plastic surgeon uses the patient's own fat obtained by liposuction to perform breast reconstruction. For more than a decade, ...
Jun 6, 2018
0
4
In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is ...
May 21, 2018
0
730
New insights into how cancer cells fuel their growth are opening novel possibilities for cancer treatment. A team of researchers at Baylor College of Medicine and Roswell Park Comprehensive Cancer Center has identified a ...
Apr 3, 2018
0
153
Mutations in human epidermal growth factor receptor 2 (HER2) were found to confer resistance to hormone therapy in some estrogen receptor (ER)-positive metastatic breast cancer cases, and resistance could be reversed by dual ...
Mar 19, 2018
0
8
Despite great advances in medicine, cancer remains a death sentence for many. "Patients are still dying from breast cancer relapse," says Jian Yuan Goh, of A*STAR's Genome Institute of Singapore. The researcher and his colleagues, ...
Mar 16, 2018
0
2
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.
Feb 15, 2018
0
27
